74733-38-3

Basic information

• Product Name: Methyl 4-(3-aMinopropyl)benzoate
• Synonyms: Methyl 4-(3-aMinopropyl)benzoate
• CAS NO: 74733-38-3
• Molecular Formula: C₁₁H₁₅NO₂
• Molecular Weight: 193.2423
• Mol File: 74733-38-3.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Methyl 4-(3-aMinopropyl)benzoate(CAS DataBase Reference)
• NIST Chemistry Reference: Methyl 4-(3-aMinopropyl)benzoate(74733-38-3)
• EPA Substance Registry System: Methyl 4-(3-aMinopropyl)benzoate(74733-38-3)

Safety Data

• Hazardous Substances Data: 74733-38-3(Hazardous Substances Data)

Upstream product

• 107-10-8 propylamine 
• 619-44-3 methyl 4-iodobenzoate 
• 79430-99-2 (E)-methyl 4-(2-cyanovinyl)benzoate 
• 117390-07-5 (E)-4-(methoxycarbonyl)cinnamic acid 
• 1571-08-0 methyl 4-formylbenzoate 
• 113100-81-5 4-(3-oxo-propyl)-benzoic acid methyl ester 
• 141018-99-7 methyl 4-<3-(methanesulfonyloxy)propyl>benzoate 
• 15403-22-2 4-(3-hydroxy-propyl)-benzoic acid methyl ester 
• 141019-00-3 methyl 4-(3-azidopropyl)benzoate 

Downstream Products

• 141019-16-1 4-<3-<(2-amino-6-methoxypyrimidin-4-yl)amino>propyl>benzoic acid 
• 141019-06-9 4-<3-<(2-amino-1,6-dihydro-6-oxopyrimidin-4-yl)amino>propyl>benzoic acid 
• 141019-09-2 N-<4-<3-<(2-amino-1,6-dihydro-6-oxopyrimidin-4-yl)amino>propyl>benzoyl>-l-glutamic acid 
• 141019-18-3 N-<4-<3-<(2-amino-6-methoxypyrimidin-4-yl)-amino>propyl>benzoyl>-L-glutamic acid 
• 141019-17-2 dimethyl N-<4-<3-<(2-amino-6-methoxypyrimidin-4-yl)-amino>propyl>benzoyl>-L-glutamate 
• 141019-08-1 dimethyl N-<4-<3-<(2-amino-1,6-dihydro-6-oxopyrimidin-4-yl)amino>propyl>benzoyl>-l-glutamate 
• 203453-82-1 methyl 4-(3-((tert-butoxycarbonyl)amino)propyl)benzoate 
• 141019-04-7 methyl 4-<3-<<6-chloro-2-(pivaloylamino)pyrimidin-4-yl>amino>propyl>benzoate 

Relevant articles and documents

Structure-Based Design of Dual-Acting Compounds Targeting Adenosine A2AReceptor and Histone Deacetylase as Novel Tumor Immunotherapeutic Agents

Adenosine is an immunosuppressive factor in the tumor microenvironment mainly through activation of the A2A adenosine receptor (A2AR), which is a mechanism hijacked by tumors to escape immune surveillance. Small-molecule A2AR antagonists are being evaluat

HISTONE DEACETYLASE INHIBITORS

Provided herein are isoform selective histone deacetylase inhibitors of the formula (I), their derivatives, analogs, tautomeric forms, stereoisomers, polymorphs, hydrates, metabolites, prodrugs, solvates, pharmaceutically acceptable salts and compositions thereof. These compounds are isoform selective inhibitors of HDACs and are useful as a therapeutic or ameliorating agent for diseases that are involved in cellular growth such as cancer, malignant tumors, autoimmune diseases, skin diseases, fungal infections, protozoal infections, HIV, inflammation and CNS disorders.